ACCELERATION OF DIGOXIN CLEARANCE BY ACTIVATED-CHARCOAL

被引：69

作者：

LALONDE, RL

DESHPANDE, R

HAMILTON, PP

MCLEAN, WM

GREENWAY, DC

机构：

[1] OTTAWA GEN HOSP,DEPT PHARM,OTTAWA K1H 8L6,ONTARIO,CANADA

[2] OTTAWA GEN HOSP,DEPT ANESTHESIA,OTTAWA K1H 8L6,ONTARIO,CANADA

[3] OTTAWA GEN HOSP,DEPT LAB MED,OTTAWA K1H 8L6,ONTARIO,CANADA

[4] UNIV OTTAWA,DEPT PHARMACOL,OTTAWA K1N 6N5,ONTARIO,CANADA

[5] UNIV OTTAWA,DEPT ANESTHESIA,OTTAWA K1N 6N5,ONTARIO,CANADA

[6] UNIV OTTAWA,DEPT PATHOL,OTTAWA K1N 6N5,ONTARIO,CANADA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 37卷 / 04期

关键词：

D O I：

10.1038/clpt.1985.55

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：367 / 371

页数：5

相关论文

共 25 条

[21] MODEL FOR THEOPHYLLINE OVERDOSE TREATMENT WITH ORAL ACTIVATED-CHARCOAL
RADOMSKI, L
PARK, GD
GOLDBERG, MJ
SPECTOR, R
JOHNSON, GF
QUEE, CK
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (03) : 402 - 408
[22] HEMOPERFUSION IN THE MANAGEMENT OF DIGOXIN TOXICITY - IS IT WARRANTED
SLATTERY, JT
KOUP, JR
[J]. CLINICAL PHARMACOKINETICS, 1979, 4 (05) : 395 - 399
[23] TREATMENT OF LIFE-THREATENING DIGITALIS INTOXICATION WITH DIGOXIN-SPECIFIC FAB ANTIBODY FRAGMENTS - EXPERIENCE IN 26 CASES
SMITH, TW
BUTLER, VP
HABER, E
FOZZARD, H
MARCUS, FI
BREMNER, WF
SCHULMAN, IC
PHILLIPS, A
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (22) : 1357 - 1362
[24] WAGNER JG, 1975, FUNDAMENTALS CLIN PH
[25] DIGOXIN OVERDOSE - LIMITATIONS OF HEMOPERFUSION-HEMODIALYSIS TREATMENT
WARREN, SE
FANESTIL, DD
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 242 (19): : 2100 - 2101